nach oben

Erschienen in:

20.07.2021 | Koronare Herzerkrankung | Positionspapiere Zur Zeit gratis

Behandlung von chronischen Koronarverschlüssen (CTO) – Positionspapier der Deutschen Gesellschaft für Kardiologie

verfasst von: PD Dr. med. Kambis Mashayekhi, Alexander Bufe, Gerald S. Werner, Nikos Werner, Markus Meyer-Gessner, Christoph Liebetrau, Ralf Zahn, Benny Levenson, Helge Möllmann, Holger Nef, Michael Behnes

Erschienen in: Die Kardiologie | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die perkutane Koronarintervention (PCI) von chronischen Koronarverschlüssen (CTO-PCI) hat sich in der letzten Dekade stetig weiterentwickelt und geht mittlerweile mit Erfolgsraten von über 85 % einher. Die Ausbildung zum selbstständigen CTO-Operateur dauert oft mehrere Jahre und Bedarf neben institutionellen Voraussetzungen eines hohen Eigenengagements zur ständigen Weiterbildung. Randomisierte Daten konnten zwar eine symptomatische Verbesserung, aber bisher keine Mortalitätssenkung nach erfolgreicher Koronarintervention zeigen. Umso entscheidender ist die richtige Patientenauswahl verbunden mit einer niedrigen periinterventionellen Komplikationsrate. Um dies zu gewährleisten, hat sich die Deutsche Gesellschaft für Kardiologie (DKG) entschieden, ein Positionspapier für alle in Praxen und Krankenhäusern tätigen Kardiologen, insbesondere aber auch für alle interventionellen Kardiologen zu verfassen. Zielführend erscheint eine bundesweite Etablierung von spezialisierten CTO-Zentren. Nur dadurch können diese hochkomplexen Prozeduren dem Patienten gegenüber mit einem niedrigen und somit vertretbaren Risiko angeboten werden.

Stone GW, Kandzari DE, Mehran R, Colombo A, Schwartz RS, Bailey S, Moussa I, Teirstein PS, Dangas G, Baim DS, Selmon M, Strauss BH, Tamai H, Suzuki T, Mitsudo K, Katoh O, Cox DA, Hoye A, Mintz GS, Grube E, Cannon LA, Reifart NJ, Reisman M, Abizaid A, Moses JW, Leon MB, Serruys PW (2005) Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I. Circulation 112(15):2364–2372PubMedCrossRef

Fefer P, Knudtson ML, Cheema AN, Galbraith PD, Osherov AB, Yalonetsky S, Gannot S, Samuel M, Weisbrod M, Bierstone D, Sparkes JD, Wright GA, Strauss BH (2012) Current perspectives on coronary chronic total occlusions: the Canadian multicenter chronic total occlusions registry. J Am Coll Cardiol 59(11):991–997PubMedCrossRef

Ramunddal T, Hoebers LP, Henriques JP, Dworeck C, Angeras O, Odenstedt J, Ioanes D, Olivecrona G, Harnek J, Jensen U, Aasa M, Albertsson P, Wedel H, Omerovic E (2016) Prognostic impact of chronic total occlusions: a report from SCAAR (Swedish coronary angiography and angioplasty registry). JACC Cardiovasc Interv 9(15):1535–1544PubMed

Ramunddal T, Hoebers LP, Henriques JP, Dworeck C, Angeras O, Odenstedt J, Ioanes D, Olivecrona G, Harnek J, Jensen U, Aasa M, Jussila R, James S, Lagerqvist B, Matejka G, Albertsson P, Omerovic E (2014) Chronic total occlusions in Sweden—a report from the Swedish coronary angiography and angioplasty registry (SCAAR). PLoS One 9(8):e103850PubMedPubMedCentralCrossRef

Werner GS, Surber R, Ferrari M, Fritzenwanger M, Figulla HR (2006) The functional reserve of collaterals supplying long-term chronic total coronary occlusions in patients without prior myocardial infarction. Eur Heart J 27(20):2406–2412PubMedCrossRef

Stuijfzand WJ, Driessen RS, Raijmakers PG, Rijnierse MT, Maeremans J, Hollander MR, Lammertsma AA, van Rossum AC, Dens J, Nap A, van Royen N, Knaapen P (2017) Prevalence of ischaemia in patients with a chronic total occlusion and preserved left ventricular ejection fraction. Eur Heart J Cardiovasc Imaging 18(9):1025–1033PubMedCrossRef

Schumacher SP, Kockx M, Stuijfzand WJ, Driessen RS, van Diemen PA, Bom MJ, Everaars H, Raijmakers PG, Boellaard R, van Rossum AC, Opolski MP, Nap A, Knaapen P (2020) Ischaemic burden and changes in absolute myocardial perfusion after chronic total occlusion percutaneous coronary intervention. EuroIntervention 16(6):e462–e71PubMedCrossRef

Schumacher SP, Everaars H, Stuijfzand WJ, Huynh JW, van Diemen PA, Bom MJ, de Winter RW, van Loon RB, van de Ven PM, van Rossum AC, Opolski MP, Nap A, Knaapen P (2020) Coronary collaterals and myocardial viability in patients with chronic total occlusions. EuroIntervention 16(6):e453–e61PubMedCrossRef

Werner GS, Fritzenwanger M, Prochnau D, Schwarz G, Ferrari M, Aarnoudse W, Pijls NH, Figulla HR (2006) Determinants of coronary steal in chronic total coronary occlusions donor artery, collateral, and microvascular resistance. J Am Coll Cardiol 48(1):51–58PubMedCrossRef

10.

McEntegart MB, Badar AA, Ahmad FA, Shaukat A, MacPherson M, Irving J, Strange J, Bagnall AJ, Hanratty CG, Walsh SJ, Werner GS, Spratt JC (2016) The collateral circulation of coronary chronic total occlusions. EuroIntervention 11(14):e1596–603PubMedCrossRef

11.

Mashayekhi K, Behnes M, Akin I, Kaiser T, Neuser H (2016) Novel retrograde approach for percutaneous treatment of chronic total occlusions of the right coronary artery using ipsilateral collateral connections: a European centre experience. EuroIntervention 11(11):e1231–6PubMedCrossRef

12.

Azzalini L, Agostoni P, Benincasa S, Knaapen P, Schumacher SP, Dens J, Maeremans J, Kraaijeveld AO, Timmers L, Behnes M, Akin I, Toma A, Neumann FJ, Colombo A, Carlino M, Mashayekhi K (2017) Retrograde chronic total occlusion percutaneous coronary intervention through ipsilateral collateral channels: a multicenter registry. JACC Cardiovasc Interv 10(15):1489–1497PubMedCrossRef

13.

Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Juni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO, ESC Scientific Document Group (2019) 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J 55(1):4–90. https://doi.org/10.1093/ejcts/ezy289CrossRef

14.

Maron DJ, Hochman JS, Reynolds HR, Bangalore S, O’Brien SM, Boden WE et al (2020) Initial invasive or conservative strategy for stable coronary disease. N Engl J Med 382:1395–1407PubMedPubMedCentralCrossRef

15.

Garcia S, Sandoval Y, Roukoz H, Adabag S, Canoniero M, Yannopoulos D, Brilakis ES (2013) Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies. J Am Coll Cardiol 62(16):1421–1431PubMedCrossRef

16.

Sandoval Y, Brilakis ES, Garcia S (2016) Completeness of revascularization in multivessel coronary artery disease. J Thorac Dis 8(11):E1493–E6PubMedPubMedCentralCrossRef

17.

Vander Salm TJ, Kip KE, Jones RH, Schaff HV, Shemin RJ, Aldea GS, Detre KM (2002) What constitutes optimal surgical revascularization? Answers from the bypass angioplasty revascularization investigation (BARI). J Am Coll Cardiol 39(4):565–572PubMedCrossRef

18.

Leviner DB, Torregrossa G, Puskas JD (2018) Incomplete revascularization: what the surgeon needs to know. Ann Cardiothorac Surg 7(4):463–469PubMedPubMedCentralCrossRef

19.

Sianos G, Werner GS, Galassi AR, Papafaklis MI, Escaned J, Hildick-Smith D, Christiansen EH, Gershlick A, Carlino M, Karlas A, Konstantinidis NV, Tomasello SD, Di Mario C, Reifart N, EuroCTO Club (2012) Recanalisation of chronic total coronary occlusions: 2012 consensus document from the EuroCTO club. EuroIntervention 8(1):139–145PubMedCrossRef

20.

Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, Prescott E, Storey RF, Deaton C, Cuisset T, Agewall S, Dickstein K, Edvardsen T, Escaned J, Gersh BJ, Svitil P, Gilard M, Hasdai D, Hatala R, Mahfoud F, Masip J, Muneretto C, Valgimigli M, Achenbach S, Bax JJ, ESC Scientific Document Group (2020) 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 41(3):407–477PubMedCrossRef

21.

Tomasello SD, Boukhris M, Giubilato S, Marza F, Garbo R, Contegiacomo G, Marzocchi A, Niccoli G, Gagnor A, Varbella F, Desideri A, Rubartelli P, Cioppa A, Baralis G, Galassi AR (2015) Management strategies in patients affected by chronic total occlusions: results from the Italian registry of chronic total occlusions. Eur Heart J 36(45):3189–3198PubMedCrossRef

22.

Mehran R, Brodie B, Cox DA, Grines CL, Rutherford B, Bhatt DL, Dangas G, Feit F, Ohman EM, Parise H, Fahy M, Lansky AJ, Stone GW (2008) The harmonizing outcomes with RevasculariZatiON and stents in acute myocardial infarction (HORIZONS-AMI) trial: study design and rationale. Am Heart J 156(1):44–56PubMedCrossRef

23.

Claessen BE, Dangas GD, Weisz G, Witzenbichler B, Guagliumi G, Mockel M, Brener SJ, Xu K, Henriques JP, Mehran R, Stone GW (2012) Prognostic impact of a chronic total occlusion in a non-infarct-related artery in patients with ST-segment elevation myocardial infarction: 3‑year results from the HORIZONS-AMI trial. Eur Heart J 33(6):768–775PubMedCrossRef

24.

Bataille Y, Dery JP, Larose E, Dery U, Costerousse O, Rodes-Cabau J, Gleeton O, Proulx G, Abdelaal E, Machaalany J, Nguyen CM, Noel B, Bertrand OF (2012) Deadly association of cardiogenic shock and chronic total occlusion in acute ST-elevation myocardial infarction. Am Heart J 164(4):509–515PubMedCrossRef

25.

Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Fuhrmann J, Bohm M, Ebelt H, Schneider S, Schuler G, Werdan K, IABP-SHOCK II Trial Investigators (2012) Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 367(14):1287–1296PubMedCrossRef

26.

Braik N, Guedeney P, Behnes M, Desch S, Barthelemy O, Sandri M, de Waha-Thiele S, Fuernau G, Rouanet S, Hauguel-Moreau M, Zeitouni M, Overtchouk P, Ouarrak T, Schneider S, Zeymer U, Thiele H, Montalescot G, Akin I (2021) Impact of chronic total occlusion and revascularization strategy in patients with infarct-related cardiogenic shock: a subanalysis of the culprit-shock trial. Am Heart J 232:185–193PubMedCrossRef

27.

Saad M, Fuernau G, Desch S, Eitel I, de Waha S, Poss J, Ouarrak T, Schneider S, Zeymer U, Thiele H (2018) Prognostic impact of non-culprit chronic total occlusions in infarct-related cardiogenic shock: results of the randomised IABP-SHOCK II trial. EuroIntervention 14(3):e306–e13PubMedCrossRef

28.

Nombela-Franco L, Mitroi CD, Fernandez-Lozano I, Garcia-Touchard A, Toquero J, Castro-Urda V, Fernandez-Diaz JA, Perez-Pereira E, Beltran-Correas P, Segovia J, Werner GS, Javier G, Luis AP (2012) Ventricular arrhythmias among implantable cardioverter-defibrillator recipients for primary prevention: impact of chronic total coronary occlusion (VACTO primary study). Circ Arrhythm Electrophysiol 5(1):147–154PubMedCrossRef

29.

Nombela-Franco L, Iannaccone M, Anguera I, Amat-Santos IJ, Sanchez-Garcia M, Bautista D, Calvelo MN, Di Marco A, Moretti C, Pozzi R, Scaglione M, Canadas V, Sandin-Fuentes M, Arenal A, Bagur R, Perez-Castellano N, Fernandez-Perez C, Gaita F, Macaya C, Escaned J, Fernandez-Lozano I (2017) Impact of chronic total coronary occlusion on recurrence of ventricular arrhythmias in ischemic secondary prevention implantable cardioverter-defibrillator recipients (VACTO secondary study): insights from coronary angiogram and electrogram analysis. JACC Cardiovasc Interv 10(9):879–888PubMedCrossRef

30.

Di Marco A, Anguera I, Teruel L, Dallaglio P, Gonzalez-Costello J, Leon V, Nunez E, Manito N, Gomez-Hospital JA, Sabate X, Cequier A (2017) Chronic total occlusion of an infarct-related artery: a new predictor of ventricular arrhythmias in primary prevention implantable cardioverter defibrillator patients. Europace 19(2):267–274PubMed

31.

Behnes M, Akin I, Kuche P, Schupp T, Reiser L, Bollow A, Taton G, Reichelt T, Ellguth D, Engelke N, El-Battrawy I, Lang S, Brilakis ES, Azzalini L, Galassi AR, Boukhris M, Neuser H, Neumann F‑J, Nienaber C, Weiß C, Borggrefe M, Mashayekhi K (2020) Coronary chronic total occlusions and mortality in patients with ventricular tachyarrhythmias. EuroIntervention 15(14):1278–1285PubMedCrossRef

32.

Behnes M, Mashayekhi K, Kuche P, Kim SH, Schupp T, von Zworowsky M, Reiser L, Bollow A, Taton G, Reichelt T, Borggrefe M, Ellguth D, Engelke N, Weidner K, Lindner S, Muller J, Ansari U, Meininghaus DG, Bertsch T, Lang S, Akin I (2020) Prognostic impact of coronary chronic total occlusion on recurrences of ventricular tachyarrhythmias and ICD therapies. Clin Res Cardiol. https://doi.org/10.1007/s00392-020-01758-yCrossRefPubMed

33.

Di Marco A, Paglino G, Oloriz T, Maccabelli G, Baratto F, Vergara P, Bisceglia C, Anguera I, Sala S, Sora N, Dallaglio P, Marzi A, Trevisi N, Mazzone P, Della Bella P (2015) Impact of a chronic total occlusion in an infarct-related artery on the long-term outcome of ventricular tachycardia ablation. J Cardiovasc Electrophysiol 26(5):532–539PubMedCrossRef

34.

Yamashita K, Igawa W, Ono M, Kido T, Okabe T, Isomura N, Araki H, Ochiai M (2019) Impact of recanalization of chronic total occlusion on left ventricular electrical remodeling. Pacing Clin Electrophysiol 42(6):712–721PubMedPubMedCentralCrossRef

35.

Suzuki Y, Tsuchikane E, Katoh O, Muramatsu T, Muto M, Kishi K, Hamazaki Y, Oikawa Y, Kawasaki T, Okamura A (2017) Outcomes of percutaneous coronary interventions for chronic total occlusion performed by highly experienced Japanese specialists: the first report from the Japanese CTO-PCI expert registry. JACC Cardiovasc Interv 10(21):2144–2154PubMedCrossRef

36.

Henriques JP, Hoebers LP, Ramunddal T, Laanmets P, Eriksen E, Bax M, Ioanes D, Suttorp MJ, Strauss BH, Barbato E, Nijveldt R, van Rossum AC, Marques KM, Elias J, van Dongen IM, Claessen BE, Tijssen JG, van der Schaaf RJ, EXPLORE Trial Investigators (2016) Percutaneous intervention for concurrent chronic total occlusions in patients with STEMI: the EXPLORE trial. J Am Coll Cardiol 68(15):1622–1632CrossRefPubMed

37.

Lee SW, Lee PH, Ahn JM, Park DW, Yun SC, Han S, Kang H, Kang SJ, Kim YH, Lee CW, Park SW, Hur SH, Rha SW, Her SH, Choi SW, Lee BK, Lee NH, Lee JY, Cheong SS, Kim MH, Ahn YK, Lim SW, Lee SG, Hiremath S, Santoso T, Udayachalerm W, Cheng JJ, Cohen DJ, Muramatsu T, Tsuchikane E, Asakura Y, Park SJ (2019) Randomized trial evaluating percutaneous coronary intervention for the treatment of chronic total occlusion. Circulation 139(14):1674–1683CrossRefPubMed

38.

Brilakis ES, Mashayekhi K, Burke MN (2019) How DECISION-CTO can help guide the decision to perform chronic total occlusion percutaneous coronary intervention. Circulation 139(14):1684–1687PubMedCrossRef

39.

Werner GS, Martin-Yuste V, Hildick-Smith D, Boudou N, Sianos G, Gelev V, Rumoroso JR, Erglis A, Christiansen EH, Escaned J, di Mario C, Hovasse T, Teruel L, Bufe A, Lauer B, Bogaerts K, Goicolea J, Spratt JC, Gershlick AH, Galassi AR, Louvard Y, EUROCTO trial investigators (2018) A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions. Eur Heart J 39(26):2484–2493CrossRefPubMed

40.

Obedinskiy AA, Kretov EI, Boukhris M, Kurbatov VP, Osiev AG, Ibn Elhadj Z, Obedinskaya NR, Kasbaoui S, Grazhdankin IO, Prokhorikhin AA, Zubarev DD, Biryukov A, Pokushalov E, Galassi AR, Baystrukov VI (2018) The IMPACTOR-CTO trial. JACC Cardiovasc Interv 11(13):1309–1311PubMedCrossRef

41.

Mashayekhi K, Neuser H, Kraus A, Zimmer M, Dalibor J, Akin I, Werner G, Aurel T, Neumann FJ, Behnes M (2017) Successful percutaneous coronary intervention improves cardiopulmonary exercise capacity in patients with chronic total occlusions. J Am Coll Cardiol 69(8):1095–1096PubMedCrossRef

42.

George S, Cockburn J, Clayton TC, Ludman P, Cotton J, Spratt J, Redwood S, de Belder M, de Belder A, Hill J, Hoye A, Palmer N, Rathore S, Gershlick A, Di Mario C, Hildick-Smith D, British Cardiovascular Intervention Society, National Institute for Cardiovascular Outcomes Research (2014) Long-term follow-up of elective chronic total coronary occlusion angioplasty: analysis from the U.K. Central cardiac audit database. J Am Coll Cardiol 64(3):235–243PubMedCrossRef

43.

Galassi AR, Boukhris M, Toma A, Elhadj Z, Laroussi L, Gaemperli O, Behnes M, Akin I, Luscher TF, Neumann FJ, Mashayekhi K (2017) Percutaneous coronary intervention of chronic total occlusions in patients with low left ventricular ejection fraction. JACC Cardiovasc Interv 10(21):2158–2170PubMedCrossRef

44.

Toma A, Stahli BE, Gick M, Gebhard C, Kaufmann BA, Mashayekhi K, Ferenc M, Buettner HJ, Neumann FJ (2017) Comparison of benefit of successful percutaneous coronary intervention for chronic total occlusion in patients with versus without reduced (〈/=40 %) left ventricular ejection fraction. Am J Cardiol 120(10):1780–1786PubMedCrossRef

45.

Hannan EL, Racz M, Holmes DR, King SB 3rd, Walford G, Ambrose JA, Sharma S, Katz S, Clark LT, Jones RH (2006) Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era. Circulation 113(20):2406–2412PubMedCrossRef

46.

Farooq V, Serruys PW, Garcia-Garcia HM, Zhang Y, Bourantas CV, Holmes DR, Mack M, Feldman T, Morice MC, Stahle E, James S, Colombo A, Diletti R, Papafaklis MI, de Vries T, Morel MA, van Es GA, Mohr FW, Dawkins KD, Kappetein AP, Sianos G, Boersma E (2013) The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (synergy between percutaneous coronary intervention with taxus and cardiac surgery) trial. J Am Coll Cardiol 61(3):282–294PubMedCrossRef

47.

Head SJ, Mack MJ, Holmes DR Jr., Mohr FW, Morice MC, Serruys PW, Kappetein AP (2012) Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3‑year SYNTAX data. Eur J Cardiothorac Surg 41(3):535–541PubMedCrossRef

48.

Hong SJ, Kim BK, Shin DH, Kim JS, Hong MK, Gwon HC, Kim HS, Yu CW, Park HS, Chae IH, Rha SW, Lee SH, Kim MH, Hur SH, Jang Y, Registry KC (2014) Usefulness of intravascular ultrasound guidance in percutaneous coronary intervention with second-generation drug-eluting stents for chronic total occlusions (from the multicenter Korean-chronic total occlusion registry). Am J Cardiol 114(4):534–540PubMedCrossRef

49.

Kim BK, Shin DH, Hong MK, Park HS, Rha SW, Mintz GS, Kim JS, Kim JS, Lee SJ, Kim HY, Hong BK, Kang WC, Choi JH, Jang Y, CTO-IVUS Study Investigators (2015) Clinical impact of intravascular ultrasound-guided chronic total occlusion intervention with Zotarolimus-eluting versus Biolimus-eluting stent implantation: randomized study. Circ Cardiovasc Interv 8(7):e2592PubMedCrossRef

50.

Brilakis ES, Mashayekhi K, Tsuchikane E, Abi Rafeh N, Alaswad K, Araya M, Avran A, Azzalini L, Babunashvili AM, Bayani B, Bhindi R, Boudou N, Boukhris M, Bozinovic NZ, Bryniarski L, Bufe A, Buller CE, Burke MN, Buttner HJ, Cardoso P, Carlino M, Christiansen EH, Colombo A, Croce K, Damas de Los Santos F, de Martini T, Dens J, di Mario C, Dou K, Egred M, ElGuindy AM, Escaned J, Furkalo S, Gagnor A, Galassi AR, Garbo R, Ge J, Goel PK, Goktekin O, Grancini L, Grantham JA, Hanratty C, Harb S, Harding SA, Henriques JPS, Hill JM, Jaffer FA, Jang Y, Jussila R, Kalnins A, Kalyanasundaram A, Kandzari DE, Kao HL, Karmpaliotis D, Kassem HH, Knaapen P, Kornowski R, Krestyaninov O, Kumar AVG, Laanmets P, Lamelas P, Lee SW, Lefevre T, Li Y, Lim ST, Lo S, Lombardi W, McEntegart M, Munawar M, Navarro Lecaro JA, Ngo HM, Nicholson W, Olivecrona GK, Padilla L, Postu M, Quadros A, Quesada FH, Prakasa Rao VS, Reifart N, Saghatelyan M, Santiago R, Sianos G, Smith E, Spratt JC, Stone GW, Strange JW, Tammam K, Ungi I, Vo M, Vu VH, Walsh S, Werner GS, Wollmuth JR, Wu EB, Wyman RM, Xu B, Yamane M, Ybarra LF, Yeh RW, Zhang Q, Rinfret S (2019) Guiding principles for chronic total occlusion percutaneous coronary intervention. Circulation 140(5):420–433PubMedCrossRef

51.

Galassi AR, Werner GS, Boukhris M, Azzalini L, Mashayekhi K, Carlino M, Avran A, Konstantinidis NV, Grancini L, Bryniarski L, Garbo R, Bozinovic N, Gershlick AH, Rathore S, Di Mario C, Louvard Y, Reifart N, Sianos G (2019) Percutaneous recanalisation of chronic total occlusions: 2019 consensus document from the EuroCTO Club. EuroIntervention 15(2):198–208PubMedCrossRef

52.

Christopoulos G, Kandzari DE, Yeh RW, Jaffer FA, Karmpaliotis D, Wyman MR, Alaswad K, Lombardi W, Grantham JA, Moses J, Christakopoulos G, Tarar MNJ, Rangan BV, Lembo N, Garcia S, Cipher D, Thompson CA, Banerjee S, Brilakis ES (2016) Development and validation of a novel scoring system for predicting technical success of chronic total occlusion percutaneous coronary interventions: the PROGRESS CTO (prospective global registry for the study of chronic total occlusion intervention) score. JACC Cardiovasc Interv 9(1):1–9PubMedCrossRef

53.

Danek BA, Karatasakis A, Karmpaliotis D, Alaswad K, Yeh RW, Jaffer FA, Patel MP, Mahmud E, Lombardi WL, Wyman MR, Grantham JA, Doing A, Kandzari DE, Lembo NJ, Garcia S, Toma C, Moses JW, Kirtane AJ, Parikh MA, Ali ZA, Karacsonyi J, Rangan BV, Thompson CA, Banerjee S, Brilakis ES (2016) Development and validation of a scoring system for predicting periprocedural complications during percutaneous coronary interventions of chronic total occlusions: the prospective global registry for the study of chronic total occlusion intervention (PROGRESS CTO) complications score. J Am Heart Assoc 5(10):e4272. https://doi.org/10.1161/JAHA.116.004272CrossRefPubMedPubMedCentral

54.

Morino Y, Abe M, Morimoto T, Kimura T, Hayashi Y, Muramatsu T, Ochiai M, Noguchi Y, Kato K, Shibata Y, Hiasa Y, Doi O, Yamashita T, Hinohara T, Tanaka H, Mitsudo K, J‑CTO Registry Investigators (2011) Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes: the J‑CTO (multicenter CTO registry in Japan) score as a difficulty grading and time assessment tool. JACC Cardiovasc Interv 4(2):213–221PubMedCrossRef

55.

Szijgyarto Z, Rampat R, Werner GS, Ho C, Reifart N, Lefevre T, Louvard Y, Avran A, Kambis M, Buettner HJ, Di Mario C, Gershlick A, Escaned J, Sianos G, Galassi A, Garbo R, Goktekin O, Meyer-Gessner M, Lauer B, Elhadad S, Bufe A, Boudou N, Sievert H, Martin-Yuste V, Thuesen L, Erglis A, Christiansen E, Spratt J, Bryniarski L, Clayton T, Hildick-Smith D (2019) Derivation and validation of a chronic total coronary occlusion intervention procedural success score from the 20,000-patient EuroCTO registry: the EuroCTO (CASTLE) score. JACC Cardiovasc Interv 12(4):335–342PubMedCrossRef

56.

Kalogeropoulos AS, Alsanjari O, Keeble TR, Tang KH, Konstantinou K, Katsikis A, Jagathesan R, Aggarwal RK, Clesham GJ, Kelly PA, Werner GS, Hildick-Smith D, Davies JR, Karamasis G (2020) CASTLE score versus J‑CTO score for the prediction of technical success in chronic total occlusion percutaneous revascularisation. EuroIntervention 15(18):e1615–e23PubMedCrossRef

57.

Forouzandeh F, Suh J, Stahl E, Ko YA, Lee S, Joshi U, Sabharwal N, Almuwaqqat Z, Gandhi R, Lee HS, Ahn SG, Gogas BD, Douglas JS, Robertson G, Jaber W, Karmpaliotis D, Brilakis ES, Nicholson WJ, King SB 3rd, Samady H (2018) Performance of J‑CTO and PROGRESS CTO scores in predicting angiographic success and long-term outcomes of percutaneous coronary interventions for chronic total occlusions. Am J Cardiol 121(1):14–20PubMedCrossRef

58.

Ybarra LF, Rinfret S, Brilakis ES, Karmpaliotis D, Azzalini L, Grantham JA, Kandzari DE, Mashayekhi K, Spratt JC, Wijeysundera HC, Ali ZA, Buller CE, Carlino M, Cohen DJ, Cutlip DE, De Martini T, Di Mario C, Farb A, Finn AV, Galassi AR, Gibson CM, Hanratty C, Hill JM, Jaffer FA, Krucoff MW, Lombardi WL, Maehara A, Magee PFA, Mehran R, Moses JW, Nicholson WJ, Onuma Y, Sianos G, Sumitsuji S, Tsuchikane E, Virmani R, Walsh SJ, Werner GS, Yamane M, Stone GW, Rinfret S, Stone GW, Chronic Total Occlusion Academic Research Consortium (2021) Definitions and clinical trial design principles for coronary artery chronic total occlusion therapies: CTO-ARC consensus recommendations. Circulation 143(5):479–500PubMedCrossRef

59.

Azzalini L, Uretsky B, Brilakis ES, Colombo A, Carlino M (2019) Contrast modulation in chronic total occlusion percutaneous coronary intervention. Catheter Cardiovasc Interv 93(1):E24–E9PubMedCrossRef

60.

Tajti P, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Dattilo P, Toma C, Smith AJC, Uretsky B, Holper E, Wyman RM, Kandzari DE, Garcia S, Krestyaninov O, Khelimskii D, Koutouzis M, Tsiafoutis I, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Rangan BV, Ungi I, Banerjee S, Brilakis ES (2018) The hybrid approach to chronic total occlusion percutaneous coronary intervention: update from the PROGRESS CTO registry. JACC Cardiovasc Interv 11(14):1325–1335PubMedCrossRef

61.

Dautov R, Urena M, Nguyen CM, Gibrat C, Rinfret S (2017) Safety and effectiveness of the surfing technique to cross septal collateral channels during retrograde chronic total occlusion percutaneous coronary intervention. EuroIntervention 12(15):e1859–e67PubMedCrossRef

62.

Matsuno S, Tsuchikane E, Harding SA, Wu EB, Kao HL, Brilakis ES, Mashayekhi K, Werner GS (2018) Overview and proposed terminology for the reverse controlled antegrade and retrograde tracking (reverse CART) techniques. EuroIntervention 14(1):94–101PubMedCrossRef

63.

Carlino M, Azzalini L, Colombo A (2017) A novel maneuver to facilitate retrograde wire externalization during retrograde chronic total occlusion percutaneous coronary intervention. Catheter Cardiovasc Interv 89(1):E7–E12PubMedCrossRef

64.

Mashayekhi K, Valuckiene Z, Neuser H, Akin I, Reifart N, Toma A, Neumann FJ, Behnes M (2017) Wire externalisation techniques for retrograde percutaneous coronary interventions of chronic total occlusions. EuroIntervention 13(12):e1489–e90PubMedCrossRef

65.

Harding SA, Wu EB, Lo S, Lim ST, Ge L, Chen JY, Quan J, Lee SW, Kao HL, Tsuchikane E (2017) A new algorithm for crossing chronic total occlusions from the asia pacific chronic total occlusion club. JACC Cardiovasc Interv 10(21):2135–2143PubMedCrossRef

66.

Brilakis ES, Grantham JA, Rinfret S, Wyman RM, Burke MN, Karmpaliotis D, Lembo N, Pershad A, Kandzari DE, Buller CE, DeMartini T, Lombardi WL, Thompson CA (2012) A percutaneous treatment algorithm for crossing coronary chronic total occlusions. JACC Cardiovasc Interv 5(4):367–379PubMedCrossRef

67.

Sapontis J, Salisbury AC, Yeh RW, Cohen DJ, Hirai T, Lombardi W, McCabe JM, Karmpaliotis D, Moses J, Nicholson WJ, Pershad A, Wyman RM, Spaedy A, Cook S, Doshi P, Federici R, Thompson CR, Marso SP, Nugent K, Gosch K, Spertus JA, Grantham JA (2017) Early procedural and health status outcomes after chronic total occlusion angioplasty: a report from the OPEN-CTO registry (outcomes, patient health status, and efficiency in chronic total occlusion hybrid procedures). JACC Cardiovasc Interv 10(15):1523–1534PubMedCrossRef

68.

Maeremans J, Walsh S, Knaapen P, Spratt JC, Avran A, Hanratty CG, Faurie B, Agostoni P, Bressollette E, Kayaert P, Bagnall AJ, Egred M, Smith D, Chase A, McEntegart MB, Smith WH, Harcombe A, Kelly P, Irving J, Smith EJ, Strange JW, Dens J (2016) The hybrid algorithm for treating chronic total occlusions in europe: the RECHARGE registry. J Am Coll Cardiol 68(18):1958–1970PubMedCrossRef

69.

Morino Y, Kimura T, Hayashi Y, Muramatsu T, Ochiai M, Noguchi Y, Kato K, Shibata Y, Hiasa Y, Doi O, Yamashita T, Morimoto T, Abe M, Hinohara T, Mitsudo K, J‑CTO Registry Investigators (2010) In-hospital outcomes of contemporary percutaneous coronary intervention in patients with chronic total occlusion insights from the J‑CTO registry (multicenter CTO registry in Japan). JACC Cardiovasc Interv 3(2):143–151PubMedCrossRef

70.

Konstantinidis NV, Werner GS, Deftereos S, Di Mario C, Galassi AR, Buettner JH, Avran A, Reifart N, Goktekin O, Garbo R, Bufe A, Mashayekhi K, Boudou N, Meyer-Gessner M, Lauer B, Elhadad S, Christiansen EH, Escaned J, Hildick-Smith D, Carlino M, Louvard Y, Lefevre T, Angelis L, Giannopoulos G, Sianos G, Euro CTO Club (2018) Temporal trends in chronic total occlusion interventions in europe. Circ Cardiovasc Interv 11(10):e6229PubMedCrossRef

71.

Azzalini L, Poletti E, Ayoub M, Ojeda S, Zivelonghi C, La Manna A, Bellini B, Lostalo A, Luque A, Venuti G, Montorfano M, Agostoni P, Pan M, Carlino M, Mashayekhi K (2019) Coronary artery perforation during chronic total occlusion percutaneous coronary intervention: epidemiology, mechanisms, management, and outcomes. EuroIntervention 15(9):e804–e11PubMedCrossRef

Titel: Behandlung von chronischen Koronarverschlüssen (CTO) – Positionspapier der Deutschen Gesellschaft für Kardiologie
verfasst von: PD Dr. med. Kambis Mashayekhi
Alexander Bufe
Gerald S. Werner
Nikos Werner
Markus Meyer-Gessner
Christoph Liebetrau
Ralf Zahn
Benny Levenson
Helge Möllmann
Holger Nef
Michael Behnes
Publikationsdatum: 20.07.2021
Verlag: Springer Medizin
Schlagwort: Koronare Herzerkrankung
Erschienen in: Die Kardiologie / Ausgabe 4/2021
Print ISSN: 2731-7129
Elektronische ISSN: 2731-7137
DOI: https://doi.org/10.1007/s12181-021-00486-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2021

Betablocker nach Infarkt: Dauertherapie für alle! Oder doch nicht?

Effekt der COVID-19-Pandemie und des Lockdowns auf die Inzidenz von Herzinfarktpatienten in Deutschland – Ergebnisse einer Metaanalyse

ESC-Leitlinie Vorhofflimmern – für Sie kommentiert

Kommentar zu den Leitlinien (2020) der ESC zu Sportkardiologie und körperlichem Training für Patienten mit kardiovaskulären Erkrankungen

Rezidivierende Stürze und Schwindel im Alter